Ibex Wealth Advisors Buys New Stake in UnitedHealth Group

Institutional investor acquires over 22,000 shares of healthcare conglomerate

Mar. 3, 2026 at 8:39am

Ibex Wealth Advisors, an institutional investor, acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter, according to a recent SEC filing. The firm purchased 22,642 shares of the healthcare conglomerate's stock, valued at approximately $7.8 million.

Why it matters

UnitedHealth Group is one of the largest healthcare companies in the United States, providing a range of insurance and healthcare services. The acquisition of a new stake by Ibex Wealth Advisors suggests the firm sees potential in UnitedHealth Group's future performance and growth prospects.

The details

According to the 13F filing, Ibex Wealth Advisors purchased 22,642 shares of UnitedHealth Group in the third quarter. This new position is valued at approximately $7.8 million. The filing also shows that other major institutional investors, such as Geode Capital Management, Dodge & Cox, and Charles Schwab Investment Management, have significant holdings in UnitedHealth Group.

  • Ibex Wealth Advisors acquired the new stake in UnitedHealth Group during the third quarter of the year.

The players

Ibex Wealth Advisors

An institutional investor that acquired a new stake in UnitedHealth Group.

UnitedHealth Group Incorporated

A diversified healthcare company that provides a broad range of health benefits and healthcare services in the United States.

Geode Capital Management

A large institutional investor that holds a significant position in UnitedHealth Group.

Dodge & Cox

An investment management firm that is a major shareholder of UnitedHealth Group.

Charles Schwab Investment Management Inc.

An investment management firm that has a large position in UnitedHealth Group.

Got photos? Submit your photos here. ›

The takeaway

The acquisition of a new stake in UnitedHealth Group by Ibex Wealth Advisors suggests the firm sees potential in the healthcare conglomerate's future performance. This move aligns with the broader trend of major institutional investors maintaining significant holdings in UnitedHealth Group, underscoring the company's importance in the healthcare sector.